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Abstract. This review focuses on the properties and roles of distinct subsets among 
the primary and the memory B lymphocytes regarding their contribution to helper- 
T-cell-dependent and -independent antibody responses. The naive/memory B cell 
functions are explained in the context of current concepts on the basic mechanisms 
of humoral immunity. Differences between murine and human B cells are also 
discussed. 
Continuous B cell production maintains primary B repertoires 
New B cells are produced at a high rate from hematopoietic stem cells until ad- 
vanced age in humans [59]. This maintains primary B cell repertoires for the consti- 
tutive production of natural antibodies, and for the generation of T-independent and 
T-dependent adaptive immune responses to antigens to which the organism becomes 
exposed. The V(D)J DNA rearrangements which create the primary B cell antigen 
receptor (BCR) specificity repertoires occur in a context of non-random utilization of 
variable region (V) genes reflecting the evolutionary pressures to produce antibodies 
reacting with frequent pathogens [1]. 
At the immature B cell stage, where a BCR formed of ~t heavy and kappa (or 
lambda) light chains becomes expressed at the cell surface for the first time, self- 
reactivity generates signals that lead to receptor editing: replacement of unsuitable 
V regions by re-rearrangement of DNA. This occurs frequently; it is only if such ed- 
iting fails within an allowed time frame that apoptosis occurs [ 10]. The bone marrow 
environment permits editing [61]. The immature B cells then undergo final matura- 
tion in the periphery in contact with all the tissues accessible to recirculating cells. 
Strong self-reactivity causes apoptosis, weaker eactivity causes different degrees of 
inactivation called anergy. Anergic cells still can be recruited into immune responses 
by appropriate activation signals. A low level of self-reactivity leads to positive 
selection of B 1 B cells producing the natural antibodies [28]. Differentiation i to this 
B sublineage thus seems to be instructed by BCR signals. However, all naive B cells 
must express a BCR to survive. 
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The set point of the BCR molecular signalosome [20], which determines these 
outcomes according to spatial density and affinity of self-determinants, a  well as to 
B maturation stage, is influenced by signals from a variety of other receptors that 
modulate the BCR signal, such as CD5, CD22, FcyR2b, PD-1 receptor, etc. [18, 54]. 
Reduced capacity for anergy and apoptosis causes increased self-reactivity, usually 
together with expansion of B 1 B cells. Coexpression of IgD together with IgM de- 
fines mature B cells. IgD seems to exert subtle effects on B cell activation/tolerance, 
so subtle that 6 knockout is irrelevant for the life of a laboratory mouse. 
Symbiosis of B cells with their microenvironments 
Distinct 13 sublineages emigrating from the bone marrow express different chemo- 
kine receptors and homing molecules which direct them according to combinatorial 
codes to different microenvironments [ 13]. B 1 B cells migrate mainly into peritoneal 
and pleural tissues/cavities. Of the other ("conventional" or B2) B cells, some home 
to the primary B follicles of either the Peyer's patches of gut-associated lymphoid 
tissue (GALT) or other mucosa-associated lymphoid tissue (MALT), and/or the 
spleen or lymph nodes. Other B2 cells home to the splenic marginal zone and micro- 
environments corresponding functionally to the splenic maNinal zone between folli- 
cles in human lymph nodes and Peyer's patches [48]. The marginal zone is a macro- 
phage- and dendritic cell-rich microenvironment which favors T-independent B re- 
sponses. It is located at the white-red pulp junction, close to the sinuses where the 
circulating antigens arrive. The tyrosine kinase Pyk-2 and the transcription factor 
Aiolus must be expressed in murine B cells for marginal zone homing [26]. In a 
symbiotic relationship the B cells actively support he development and maintenance 
of the microenvironments on which they depend. B cells are required for the devel- 
opment of Peyer's patches including M cells [22]. B cells produce lymphotoxin ct213 
and tumor necrosis factor ct (TNFct) for the follicular stroma cells [3]. Only a minor- 
ity of the newly generated B cells become relatively tong-lived cells that recirculate 
between blood and their borne environments. All primary B cells must express an 
antigen receptor for survival and for homeostatic expansion to predetermined cell 
levels. This is also the case for naive T cells. The TCR-proximal tyrosine kinase 
p561ck is necessary for homeostatic proliferation, but not for survival [64]. 
Pre-B cells in the bone marrow express the Ia heavy chain; the splicing required 
for ~) expression - which experimentally can replace )a for B maturation - is normally 
suppressed. Mice unable to express ~ or (5 were found to generate IgA B cells quite 
abundantly as well as intestinal IgA antibodies [41]. In these mice, bone-marrow- 
derived cells mature to pre-B and further stages in the GALT, but not in the bone 
marrow. Conventional B cells capable of generating T-independent adaptive [gA re- 
sponses as well as lgA-producing B I cells are apparently generated in the GALT. 
Possibly this pathway may also be important in normal mice and humans. 
Natural antibodies 
The natural antibodies, which are mainly IgM and, in the MALT, to a large extent 
IgA, as found in mice, are important as first-line defense against microorganisms 
[18, 41, 50]. T-independent as well as ,//~)-T-cell-dependent mechanisms participate 
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in the differentiation of the B I into plasma cells [78]. B1 B cells and some ,/16- 
T cells can be considered as part of natural immunity. The B 1 cells may be positively 
selected not only by self-antigens but also by determinants of the constitutive com- 
mensal bacterial flora in the gut. B 1 cells frequently express CD5. This inhibitory re- 
ceptor [7] is also found on anergic B cells [30] and on B cells recently activated by 
T cells in vitro [24]. This means that the self-reactivity of the B1 cells is constantly 
controlled, and that CD5 is not a specific marker for B lcells. The natural antibodies 
generally show broad cross-reactivity with soluble and cellular self-antigens (low- 
affinity polyreactive antibodies); they neutralize some pathogens quite efficiently 
[50]. Most likely, B 1 cells can also be recruited into adaptive immune responses. 
Antigen recognition in immunological synapses 
Chronically persisting antigens are tolerogenic, i.e. as if they were all self-determi- 
nants. Chronic BCR ligation leads to diminished calcium signaling. This is sufficient 
for activation of the transcription factor NFATc, but not for that of NFI<B, the key 
transcription factor for lymphocyte activation. Because the stimulatory effects of 
NFATc mainly occur by synergism with NFKB, the inhibitory effects of this multi- 
functional transcription factor predominate [23]. Adaptive immune responses thus 
occur in response to an acute increase of antigen. The primary responses take place 
only in the secondary l mphoid tissues [83]. T-dependent and probably most T-inde- 
pendent antigens (at least in humans) are recognized by the B cells on professional 
antigen-presenting cells (APC), such as migrating dendritic ells (DC) or resident 
follicular dendritic ells (FDC), by the formation of an immunological synapse. 
A synapse is formed by large membrane areas of polarized interacting cells [5, 
16, 46]. The antigen receptors and the many other eceptors for positive and negative 
signals are spatially organized, together with their signaling modules, in complex 
concentric onfigurations that change over time: first one finds the adhesion mole- 
cules and later on the antigen/antigen receptors in the central supramolecular ctiva- 
tion cluster (c-SMAC). This requires dynamic cytoskeletal lterations and adaptors 
for the linkage of the signaling components. WASR the protein deficient in Wiskott- 
Aldrich syndrome, is such an adapter [16]. T-independent B cell responses to the 
polysaccharides of encapsulated bacteria re particularly affected by this condition. 
One aspect of the synapses then is that positive and negative signals are orga- 
nized. Phosphatase CD45, which is required for activation of antigen-receptor- 
associated tyrosine kinases, is at one time moved to the periphery of the T-cell-APC 
synapse, but later on retransported into the center by means of endosome traffic [16]. 
The list of cellular eceptors that inhibit B cell activation is rapidly growing [18, 54]. 
B cell activation signals also favor expression of or signaling from inhibitory recep- 
tors [23]. One can assume that ligands on various tissues suppress B cell activation, 
in analogy to the protective function of CD47 on red blood cells against phagocyto- 
sis by macrophages [51]. In particular, synapsing is required for the proper activation 
of naive lymphocytes. 
Another aspect is antigen concentration i  the c-SMAC. Rare antigens bound to 
the APC (e.g. via complement receptors) become concentrated. The BCR become 
concentrated in the glycolipid-enriched membrane domains called lipid rafts, linked 
to their signalosomes. B cells selectively internalize the BCR that bind antigen, for 
processing and presentation of peptides on MHC class II to a potential helper T cell. 
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Even antigen presented as a transmembrane molecule on an APC can be internalized, 
by membrane pinching [5]. 
Synapses and properties of T-independent antigens 
For many microbial antigens, the DC and / or B cells are equipped with receptors of 
innate immunity, such as the Toll-like receptors for Escherichia coli lipopolysaccha- 
ride (TLR4), bacterial CpG DNA (TLR9), etc. [53]. T-independent type 1 (TI-1) an- 
tigens react with such receptors. Human B cells express some toll-like receptors 
(TLR) [49]; TLR2 (a receptor for peptidoglycans form Staphylococcus aureus) is 
found on GC B cells, but not on peripheral blood B cells [19]. However, in contrast 
to murine B cells, human B cells do not respond to lipopolysaccharide. Costimulato- 
ry molecules leading to B cell activation occur on DC and FDC, e.g. DC-8 on human 
FDC [37]. Thus, these cells can transfer their activation state onto the B cells. 
TI-2 antigens cause extensive BCR cross-linking; they are formed by arrays of re- 
petitive determinants in a rigid form, such as occur on many bacteria nd viruses [76, 
83]. In contrast o naive murine B cells, in vitro stimulation of naive human B cells 
by extensive BCR cross-linking [anti-Ig antibodies on beads or coated plates, or pro- 
tein-A-rich S. aureus Cowan I (SAC)], alone or together with many cytokines, in- 
cluding BAFF/BIyS [63], does not lead to Ig secretion, only some proliferation. Even 
CD40 ligation together with B-differentiation-inducing cytokines - in the absence of 
intact T cells - does not induce Ig secretion in naive B cells [31]. Memory B cells 
can be readily induced by SAC to proliferate and secrete Ig [44, 80]. Therefore it ap- 
pears that the activation of naive B cells in particular is more tightly controlled in hu- 
mans than in mice, probably because organisms with a longer generation time must 
exercise a better control over autoimmunity. This may require synapse formation. 
How B cell activation by TI-2 relates to synapse formation remains to be eluci- 
dated. Manifestly, some antigens induce TI-2 responses better than others, indepen- 
dent of the antigen close / antigen concentration i  the c-SMAC. Affinity for the BCR 
is an independent variable [34]. Antigens can combine TI-2 and TI-I properties. 
Bacterial flagellin is an example, flagellin is recognized by TLR5 [29}. Activated 
complement (C3d) present on many TI-2 antigens in vivo reacts with the comple- 
ment receptor CD21 (on B or DC), which on B cells is linked to the activator CD19. 
In addition, the exact wo-dimensional spacing of the repetitive B epitopes on a rigid 
TI-2 antigen most likely plays a role even in synapses, possibly by maximizing the 
effects of BCR-associated tyrosine kinases on the immunoreceptor tyrosine-based 
activation motifs (ITAM) of neighboring BCR [14]. 
T-dependent immune response 
The T-dependent immune responses in the B follicles that lead to the formation of 
secondary follicles with germinal centers (GC), generate the repertoire of long-lived 
memory B cells [45, 84]. Like adaptive immunity in general, memory increases the 
probability of survival in a world in which repeated assaults by opportunistic patho- 
gens are the rule. The GC is a sophisticated incubator for B cell expansion. For the 
typical generation of 103-104 progeny from one B cell, multiple rounds of prolifera- 
tion induced by FDC-B and B-T synapses are required. Somatic V(D)J hypermuta- 
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tion and Ig isotype switching are particularly frequent during the GC reaction. Affin- 
ity maturation, which involves hypermutation together with cell selection, seems to 
exclusively occur in the GC under normal conditions. 
Induction of the GC response 
The T-dependent response requires "cognate" T-B interaction. For the initiation of 
the response, B cells must see, on a DC (or FDC), an antigen which, after internal- 
ization and enzymatic processing, generates a peptide (T epitope) presentable on 
MHC class II. Helper T cells must see antigen first on a DC, and a T cell must then 
recognize on a B cell the same peptide together with the same MHC class II that it 
has seen on a DC. The chemokine receptor CXCR5 participates in the homing of re- 
circulating B cells to follicles; the ligand CXCL 13 is elaborated by FDC [13, 62]. 
Some studies in mice indicate that the B cell encounters the antigen on a DC for the 
first time when it travels from the high endothelial venules to the follicle through the 
T zone of the lymph node. The B cell then also encounters a specific helper T cell 
during its journey. Other data indicate that B cells first recognize the antigen on an 
FDC in the follicle [21]. FDC efficiently capture antigens coated with antibody (nat- 
ural antibody or cross-reactive memory antibody) and/or complement C3d, which 
arrive through lymphatics. In this case, the B cell must encounter a T cell at the edge 
of (or within) the follicle. Both scenarios may occur depending on the site of the first 
encounter with antigen. 
Depending on the nature of the antigen, a T-independent B response can be initi- 
ated in the GC [75]. Sooner or later a few activated helper T cells that also express 
CXCR5 - a species of T cell not fitting into the Thl/Th2 paradigm - migrate into the 
follicle [40, 62]. Initial costimulation of the T cell by the DC involves B7-1/2 inter- 
action with CD28 constitutively expressed on the T cells. Activated T cells then ex- 
press the inducible costimulator ICOS. The B cell has the ligand, B7RP-1. The B cell 
has to stimulate the T cell to elicit helper functions mediated by CD40L and other 
cell-bound or secreted T molecules [70]. The B cell also stimulates the T cell with 
OX40L; many TNF-family molecules (CD40L, CD27L, CD30L, OX40L, 4-1BBL, 
TNF, FasL, BAFF) and their receptors are involved in T-B collaboration [38]. Even- 
tually, about two or three B cells per GC generate xpanded clones. The cells prolif- 
erate as large centroblasts in the dark zone of the GC. After a few rapid divisions, 
one every 6-8 h, they become smaller centrocytes and localize to the FDC network 
in the apical light zone where the GC T cells also reside. Here reactivation takes 
place. Obviously the antibody response should start early after infection by a patho- 
gen. Thus, B cells leave the GC after various numbers of proliferation cycles, some 
B cells stay in the GC for 2 weeks or longer. 
Switching and hypermutation 
Hypermutation and Ig class switching occur in the proliferating cells. Both processes 
are mechanistically transcription-coupled. Hypermutation involves DNA double- 
strand breaks during transcription of V regions, followed by repair by components of 
DNA, "mismatch repair", in conjunction with several error-prone, lesion-bypass 
DNA polymerases [52, 69]. Polymerase Xl is an A-T mutator in this process, as 
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found in patients with variant xeroderma pigmentosum with a deficiency of this 
polymerase [81]. The specific signals inducing hypermutation are not yet known; 
CD40L is not essential [79]. 
Class switching occurs as a result of recombination between certain DNA regions 
located upstream of each Ig heavy-chain constant region. The essential regions re- 
main to be discovered; the classical tandem-repeat l  switch region is important but 
not essential for switching starting from IgM [39]. Cytokine signals select arget re- 
gions for switching, by inducing chromatin modification and generation of germline 
transcripts from the targeted regions [68]. DNA recombination then occurs, linking 
VDJ to a new constant region located further downstream than the one initially ex- 
pressed. Valious components of non-homologous DNA end-joining that also partici- 
pate in the V(D)J recombination are utilized (DNA end-binding proteins, DNA- 
dependent kinase, but RAGI/2 are not involved in the DNA cleavage). In humans 
with a "non-leaky" CD40L defect mutation, virtually no switch occurs; this is the 
Xqinked hyper-lgM syndrome. Activation-induced cytidine deaminase (AIC) defi- 
ciency gives an autosomal hyper-IgM syndrome as well as lack of hypermutation 
[58]. AIC could be an RNA-editing enzyme. Thus, related proteins resulting fiom 
this RNA editing may participate in both processes. In humans with severe combined 
immunodeficiency with normal B cells (i.e. T cell deficiency), it is also almost ex- 
clusively IgM that is produced. 
Various cytokines target switching to distinct IgG subclass patterns; switching to 
IgE is well known to be dependent on interleukin-4 (IL-4) or IL-13. In mice with a 
conditional (Cre/loxP-mediated) transforming growth factor ~ (TGFI3) receptor dele- 
tion, which allows testing of this receptor function in adult animals, virtually no IgA 
switch occurs [I1]. In naive or memory human B cells from peripheral blood, 
TGF~I strongly induces IgAl and IgA2 germline transcripts, but IgA switching did 
not occur in the presence of DC [4], oligomeric CD40L or mouse EL-4 thymoma 
cells [80] in the presence of many cytokines tested (C. Werner-Favre, F. Bovia, 
R. Zubler, unpublished). It is possible that IgA switching depends on MALT-type 
microenvironmental components [41]. 
Cell selection in the GC 
In conjunction with cell selection, hypermutation leads to antibody affinity matura- 
tion. Hypermutation carries the risk of producing autoantibodies. The general princi- 
ples of the cell selection for affinity maturation are well known. GC B cells are in an 
apoptosis-sensitive state; e.g. the anti-apoptotic protein Bcl-2 is down-regulated. The 
B cells need survival signals from antigen, FDC and T cells. The B cells that are 
crowded in the GC compete for antigen. Conditions leading to reduced apoptosis re- 
lax the cell selection and affinity maturation; they also increase autoantibody genera- 
tion and the risk of follicular lymphomagenesis. 
FasL/Fas-mediated apoptosis is important. Activated T and B cells express FasL 
and Fas. Because CD40L is a potent inducer of Fas, autoimmunity can even be found 
in CD40L deficiency [23]. FLIP protein competes with caspase-8 for the formation 
of the death-inducing signaling complex at the Fas death receptor. BCR cross-linking 
increases FLIP activity (in addition to various other anti-apoptotic effects, such as 
up-regulation of Bcl-xL). Murine B cells are protected from Fas death by FLIP hy- 
perexpression [74]. Using lentiviral vectors [60], we found that human B cells trans- 
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duced with viral FLIPs are completely protected from the effect of oligomeric Fas 
ligand (E Bovia, R Salmon, C. Werner-Favre, t al., studies in progress). In contrast 
to B cells, DC express FLIP constitutively and are in fact activated by FasL [57]. 
B cell activation by FasL has not been found. 
What normally happens when a BCR mutates to autoreactivity is less clear. If a 
B cell no longer presents those peptides that are recognized by the T cells in the GC, 
it should die out. T cells have a key control function. In mice expressing the influen- 
za virus hemagglutinin (HA) as self-antigen, in which naive anti-HA B cells are neg- 
atively selected, a strong anti-HA GC response and anti-HA B memory cell genera- 
tion can be induced in the presence of virus-specific helper T cells [55]. B cells 
cross-reacting with self and the original antigen pose a problem. Possibly, HLA-DO, 
a modulator of peptide presentation on MHC II in B cells, is important in the control 
of autoimmunity [27]. 
Long-lived plasma cells and memory B cells 
lg secretion does not occur in the GC; it would interfere with the cell selection for 
affinity maturation. Generally, proliferation signals inhibit differentiation i B cells. 
In proliferating B cells the transcription factor BSAP/Pax5 is a potent suppressor of 
other transcription factors required for the terminal differentiation of B cells into an- 
tibody-secreting plasma cells, such as XBP-I and Blimp-l [56, 73]. The gene repres- 
sor Bcl-6 acts on various genes for cell-cycle control [Bcl-6 can become oncogenic 
in follicular lymphoma by the V(D)J hypermutation mechanism] as well as genes for 
plasmocytic differentiation [65]. 
B cells that have been activated in an immune response (T-dependent or T-inde- 
pendent) permanently acquire CD27 expression. CD27 cross-linking in conjunction 
with [L-10 and IL-2 leads to B cell differentiation [2]. Since some T as well as 
B cells in the GC express CD27L, a certain proportion of centrocytes can leave the 
GC already committed for differentiation, equipped with homing molecules for the 
medullary chords of lymph nodes, the bone marrow, the mucosa and other sites to 
which the plasma cell precursors disseminate. Since recirculating CD27 + B cells can 
also be readily induced in vitro to become plasma cells by BCR cross-linking with 
SAC [44] and cytokines, such as IL-2 and IL-10, which they produce themselves 
[32, 84 ], other post-GC B cells could undergo plasmocytic differentiation i various 
tissues in the presence of antigen. Syndecan-1 is a marker for plasma cells. 
Some plasma cells have a long life span [45, 84]. In humans, several months of 
systemic treatment with anti-B-cell (anti-CD20) antibody for lymphoma does not 
significantly reduce the serum Ig levels [42]. Other plasma cells are short-lived (days 
to weeks), in particular those that appear first during the T-dependent response and 
home to the medullary chords in the local lymph node. The life span could depend 
on the microenvironment. It is also possible that repeated restimulation i synapses 
favors longevity of B cells, as has been proposed for T cells [36]. This would explain 
why the GC reaction generates plasma nd memory cells with a long life span. 
As with memory T cells, persisting antigen is not required for survival of memory 
B cells [43]. Recirculating human memory B cells maintain a high expression of 
Bcl-xL anti-apoptotic protein, in contrast o naive B cells [8]. When such cells are 
put in culture without stimulation, the Bcl-xL mRNA decreases rapidly, indicating 
that a high level is maintained by exogenous ignals. For memory T cells in mice, 
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IL-15, but not IL-2, provides an important survival signal [35]. Memory cells 
(B or T) undergo antigen-independent cell division from time to time; they show a 
capacity for self-renewal nd homeostatic proliferation. 
Switched and non-switched CD27 § B cells 
The human recirculating CD27+ B cells, but not the naive B cells induced to express 
CD27 by SAC in culture, have acquired the capacity for plasmocytic differentiation 
in assays in vitro [44, 80]. This reveals ome functional maturity, which may require 
T-B or DC-B synapse formation and/or still unknown B cell activators. About 45% 
of recirculating B ceils in adults are CD27 +. Among these ceils, Ig-switched cells, 
IgM + cells that lack IgD (IgM-only cells), and IgM+IgD § cells occur in similar pro- 
portions, and more than 90% of all these cells can'y V(D)J mutations [33]. Thus, a 
high proportion of non-switched, mutated B cells occur in humans. 
In patients with complete CD40L functional deficiency, both the switched and the 
IgM-only cells are lacking, whereas ome V(D)J mutated IgM+IgD § CD27 + cells are 
produced, although in most cases at low levels (1%-2% of peripheral blood B cells 
in six of eight patients, 4% and, for unknown reasons, 60% in the two others) com- 
pared to normal controls (7%-10%) [79]. Follicles are severely disorganized in 
CD40L deficiency; CD40L is also required to maintain FDC. Thus, some hypermu- 
tation could either still occur in such tissue or take place elsewhere, i.e. in the splenic 
marginal zone [79]. In some species, like sheep, diversification by V(D)J mutation 
occurs during B cell ontogeny, mainly in the GALT. The marginal zones in spleen, 
Peyer's patches and lymph nodes are indeed an important reservoir of V(D)J-mutat- 
ed B cells in adults [15, 7t, 72]. However, in hyper-IgM syndrome one expects a 
compensatory increase of the T-independent marginal zone B celt responses to infec- 
tious agents. Thus, the low levels of recirculating mutated B cells in this condition 
indicate that these normally are mostly GC-derived. Therefore, in normal individu- 
als, when they are not just undergoing an acute immune response (T-dependent or 
T-independent) with high blood levels of rapidly tissue-homing CD27 + plasma cell 
precursors, the recireulating CD27 § cells are essentially long-lived post-GC memory 
B cells. The high proportion of memory B cells may be due to the longer life span of 
humans compared to mice. 
Ig switch capacity of CD27 § B cell subsets 
Recently we investigated the Ig switch capacity of the three CD27 + B subsets [80]. 
IgM+IgD § cells switch to all IgG subclasses to the same extent as naive ceils. In con- 
trast, IgM-only cells have a very low switch activity. This suggests a switch defect, 
such as could occur when attempted switching leads to loss of certain p DNA switch 
regions. Lack of this subset in CD40L deficiency [79] accords with some switch- 
related mechanism. The CD27 + cells that had already switched to IgG in vivo 
showed no increase of IgG4 in response to IL-4. Thus, although it is known that sec- 
ondary switching to further-downstream constant regions can occur [68], at least 
some switch options are strongly reduced in cells that have already switched. 
The generation of these three post-GC subsets may reflect evolutionary pressure 
for optimization of immune responses. A tendency for "isotype stabilization" in 
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switched cells would ensure that a secondary response to the same pathogen gener- 
ates those isotypes which have been instructed by signals of natural immunity during 
the primary response [82]. The GC also produces V(D)J-mutated B cells that can 
cross-react with novel pathogens. Fully conserved switch capacity is an advantage 
when the cells respond to novel pathogens. 
Moreover, affinity maturation of IgM antibodies eems to be very important, 
although the IgM are pentameric antibodies. Many IgM antibodies to the polysaccha- 
rides of encapsulated bacteria in humans carry V(D)J mutations and, at least for 
some of these antigens, depending on the germline V repertoire, mutations increase 
the antibody affinity [1]. A cellular receptor for polymeric IgA and IgM (Fccx/laR) 
mediating phagocytosis of antibody-coated bacteria has recently been found [66], ex- 
tending the effector functions of IgM beyond antigen eutralization and complement 
activation. Also, deficiency of serum IgM in mice predisposes them to development 
of IgG autoantibodies; maintenance of a certain IgM/IgG ratio seems to be important 
[17]. IgM has a short half-life in vivo but, compared to monomeric IgG, it takes five 
times more plasma cells to produce an equal number of IgM molecules. Therefore, 
the immune system might utilize active switch suppression i the GC, and not just 
rely on the probabilistic nature of switching. GC T cells expressing CD30L can sup- 
press switching in human B cells [12]. Interestingly, this preferentially affects non- 
antigen-selected cells, i.e. possibly B cells that have mutated and no longer ecognize 
the GC-response-inducing antigen, but which can serve as functionally experienced 
cells reacting with novel pathogens. Loss of switching capacity in the IgM-only cells 
may also be a means of isotype stabilization to maintain acertain IgM level. 
Memory B cells for T-independent responses 
The capacity of the immune system to generate T-independent B responses i impor- 
tant in the case of antigens that can not induce a classical T-B collaboration, such as 
polysaccharides or phospholipids. Such responses can be enhanced by pathogen re- 
ceptors of natural immunity. Potentially, u cells recognizing non-peptide antigens 
on non-classical MHC molecules can also participate [76]. However, it is important 
to realize that not only naive but also the functionally experienced memory 
B cells can participate in T-independent responses (Fig. 1). As mentioned above, 
compared to naive cells, human memory B cells show a much enhanced response to 
T-independent s imulation. The memory B cell pool is quantitatively important in 
adults. Depending on the pathogen and the primary BCR specificity repertoire, it is 
more the functional maturity, the novel cross-reactivities or the affinity maturation of 
the memory B pool that leads to enhanced T-independent responses. Even pathogens 
that induce an almost exclusively T-independent primary response can, after repeated 
exposure, cause an accumulation of specific memory B cells. This occurs when a 
small proportion of the T-independent antigen forms covalent or non-covalent asso- 
ciations with proteins that allow for a T-dependent GC response with pathogen- 
specific or cross-reactive T helper cells. This is natural immunization corresponding 
to a low-dose polysaccharide-protein co jugate vaccine. The clinically relevant im- 
maturity of the T-independent response to the polysaccharides of encapsulated bacte- 
ria in infants aged less than 2 years [1] most likely reflects the time required to gen- 
erate memory B cells. Progressively, the marginal zones in spleen and lymph nodes 
become nriched in post-GC cells [ 15, 71, 72]. 
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Fig. 1. Participation of primary and memory B cell subsets in T-dependent and T-independent humoral im- 
mune response. Bn naive B cells, Bm memory B cells; PL plasma cells, DC dendritic ells; FDC follicular 
dendritic ells; Ttl helper T cells; MZ marginal zones; GC germinal centers 
A cytokine receptor for T-independent B responses 
The B lymphocyte activator of the TNF family (BAFF), also called B lymphocyte 
stimulator (BEyS), THANK, TALL-1 or zTNF4, has recently been discovered in hu- 
mans and mice [47, 63, 67, 77]. This cytokine acts on two known receptors, BCMA, 
which seems to be B-specific, and TACI found on B and T cells [67]. One function 
of BAFF is to act as a survival factor for immature B cells emigrating from the bone 
marrow to the spleen, i.e. for the cells in which self-tolerance has to be established 
[6]. BAFF hyperexpression in transgenic mice causes B cell hyperplasia nd autoim- 
munity. TACI-Ig fusion protein, used as a decoy receptor, decreases autoantibody 
production and autoimmune disease in NZBWFI mice [25]. APRIL a related TNF- 
family factor, is produced by various tumor cells and acts on both BAFF receptors, 
revealing new links between cancer and autoimmunity [77]. Antibodies to APRIL 
have also been found to reduce T cell activation in mice [67]. 
Regarding the T-independent B cell response, BAFF is secreted by interferon-~/- 
activated monocytes and DC [47]. TACI-knockout mice have a severe defect of TI-2 
B responses [9]. This is the first example of an important cytokine receptor for the T- 
independent response. Surprisingly, TACI-knockout mice also have twice as many B 
cells as control mice [9]. The different BAFF receptors may have opposite regulatory 
functions during B cell development. 
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Conclusions 
Continuous production of new B ceils maintains primary BCR specificity reper- 
toires. B l B cells are positively selected by weak self-reactivity. Their differentiation 
into plasma cells producing natural antibodies of mainly IgM and IgA class in mice 
occurs in the MALT and spleen, with participation of y/iS-T cells, Conventional naive 
B cell subsets home to either the marginal zones or the B follicles of secondary 
lymphoid organs, the preferential microenvironments for T-independent and 
T-dependent primary B responses respectively. The T-dependent responses in the fol- 
licular germinal centers progressively build up the repertoire of long-lived, function- 
ally experienced and V(D)J-mutated memory B cells, which eventually represent 
about half of all B cells in peripheral blood and the marginal zones in adult humans. 
These cells can undergo T-dependent and T-independent secondary responses as well 
as cross-react with novel pathogens. They express CD27 and comprise three subsets 
in similar proportions: (1) the Ig-class-switched cells, which exhibit a low second- 
,'u-y-switching capacity to at least some isotypes and thus conserve isotype patterns 
for secondary responses, (2) the IgM-onty cells, which have lost switching capacity 
and assure high-affinity IgM production for complement- and Fcct/~aR-mediated de- 
fenses, and (3) the IgM+IgD + ceils, which conserve full switching capacity and may 
therefore be optimal for cross-reactive r sponses to novel pathogens, Because of 
their functional maturity and long life span, the post-GC memory B cells are impor- 
tant for the T-independent B responses in humans. 
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